Key result
Short-term high altitude exposure is tolerated by ~100% of asymptomatic moderate-to-severe aortic stenosis patients.
Why the study?
Expert consensus advises patients with aortic stenosis to avoid high altitude due to presumed ischemia and arrhythmia risks, but robust evidence on the safety of short-time high altitude exposure in asymptomatic moderate to severe aortic stenosis is lacking.
Is short-term high altitude exposure (3454 m.a.s.l.) safe and well tolerated in individuals with asymptomatic moderate to severe aortic stenosis?
Cohort (n=8)
No
Is short-term high altitude exposure (3454 m.a.s.l.) safe and well tolerated in individuals with asymptomatic moderate to severe aortic stenosis?
Preliminary data suggest that short-term exposure to high altitude (3454 m.a.s.l.) is well tolerated and safe in patients with asymptomatic moderate to severe aortic stenosis, even during physical exertion.
Answers are grounded in this paper and cite their sources.
Tolerated in small asymptomatic AS cohort; challenges consensus but remains hypothesis-generating pending larger studies.
Background/Introduction Aortic stenosis is a common disease with increasing prevalence due to an aging population. High altitude exposure for leisure activities and tourism is popular; however, in the absence of robust evidence, pathophysiological considerations have led to an expert consensus advising patients with aortic stenosis to avoid such exposure owing to a presumed elevated risk for myocardial ischemia and arrhythmia. Purpose The aim of this study is to evaluate the safety of short-time high altitude exposure in individuals with asymptomatic moderate to severe aortic stenosis. Methods This is an ongoing prospective, monocentric cohort study enrolling patients with asymptomatic moderate to severe aortic stenosis (n=20) and age- and sex-matched controls (n=20). All participants undergo baseline assessment at low altitude (540m.a.s.l.), including transthoracic echocardiography, cardiopulmonary exercise testing, and blood analysis. These evaluations are then repeated at high altitude (3454m.a.s.l.). Results To date, 8 out of the planned 20 aortic stenosis patients (100% male, mean age 74±10 years, mean aortic valve area 1.09±0.08cm2) have been enrolled. All patients successfully completed the evaluation at high altitude, and none required premature return to low altitude. High altitude exposure was associated with a marked decrease in resting oxygen saturation (SpO2 -9.2±3.6%), an associated more pronounced decrease during exercise (delta SpO2 -7.8±1.7%) and an increase in VE/VCO2 slope (+5.4±3.7), while exercise capacity (-5.5±15.7Watt, i.e. -4%) and peak VO2 remained largely stable (+0.8±2.6ml/min/kg). Echocardiographic assessment revealed increases in left ventricular filling pressure (E/e’ +1.4±4.1) and indexed cardiac output at rest (+0.8±0.9l/min/kg), while the mean transvalvular pressure gradient remained stable (-0.7±5.3mmHg). NTproBNP levels increased by +285±502pg/ml, representing a 118% rise. Conclusion Preliminary findings from this ongoing trial suggest that short term high-altitude exposure is well tolerated in individuals with asymptomatic moderate to severe aortic stenosis, even during physical exertion.
No takes yet. Share an insight, caveat, or question.
Bigler et al. (2026) conducted a cohort in Asymptomatic moderate to severe aortic stenosis (n=8). Short-term high altitude exposure (3454 m.a.s.l.) vs. Baseline at low altitude (540 m.a.s.l.) was evaluated on Safety and tolerability of short-term high altitude exposure (completion of evaluation without premature return to low altitude). Short-term high altitude exposure (3454m) was tolerated by 100% of asymptomatic moderate-to-severe aortic stenosis patients (n=8), with stable mean gradients (-0.7mmHg) despite lower SpO2 (-9.2%).
Synapse has enriched 10 related papers. Consider them for comparative context: